Physicochemical Properties
| Molecular Formula | C7H9BO2 |
| Molecular Weight | 135.96 |
| Exact Mass | 136.069 |
| CAS # | 5720-05-8 |
| PubChem CID | 79799 |
| Appearance | Off-white to light yellow solid powder |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 275.2±33.0 °C at 760 mmHg |
| Melting Point | 256-263 °C(lit.) |
| Flash Point | 120.2±25.4 °C |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.528 |
| LogP | 2.05 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 10 |
| Complexity | 97.8 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O([H])B(C1C([H])=C([H])C(C([H])([H])[H])=C([H])C=1[H])O[H] |
| InChi Key | BIWQNIMLAISTBV-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C7H9BO2/c1-6-2-4-7(5-3-6)8(9)10/h2-5,9-10H,1H3 |
| Chemical Name | (4-methylphenyl)boronic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | 4-Tolueneboronic acid is a biochemical reagent that can be utilized in studies pertaining to life sciences as an organic substance or biological material. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (735.51 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (18.39 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (18.39 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (18.39 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.3551 mL | 36.7755 mL | 73.5510 mL | |
| 5 mM | 1.4710 mL | 7.3551 mL | 14.7102 mL | |
| 10 mM | 0.7355 mL | 3.6776 mL | 7.3551 mL |